Medivation Receives Prestigious Award From American

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Medivation Receives Prestigious Award From American Urological Association (AUA)

SAN FRANCISCO, CA --(Marketwired - May 11, 2016) - Medivation Inc. ( NASDAQ : MDVN ) announced today that it is the recipient of the 2016 Health Science Award from The American Urological Association (AUA) for outstanding support of physician and patient education in prostate cancer. The Health Science Award is presented to the company that best supports the AUA's mission to promote the highest standards of urological clinical care through education, research and formulation of healthcare policy. The award was received last night at the Annual Awards Banquet during the 2016 Annual Scientific Meeting of the AUA in San Diego.

Medivation sponsors, supports, develops, and contributes to physician and patient education in prostate cancer through a variety of programs, materials, and national, regional and local events. This educational activity is aimed at expanding the understanding and awareness of advanced prostate cancer. In addition to its support of several programs conducted in cooperation with the AUA, such as the annual scientific meeting, as well as its partnership with the AUA's Urology Care Foundation, Medivation is active with continuing medical education for healthcare professionals and deeply engaged with the prostate cancer patient advocacy community.

"Medivation has been a committed partner to and an ardent supporter of the AUA and the Urology Care Foundation, helping us increase awareness about prostate cancer through a variety of forums, as well as contributing greatly to a number of patient education efforts," said AUA Executive Vice President, Development and Publications, Kevin A. Wohlfort. "It's been three years since we've recognized an industry partner for their contributions, and we are proud to present Medivation with the Health Science Award to honor its ongoing commitment to helping patients and supporting the prostate cancer community."

In addition to its support of many physician education efforts, Medivation is involved with the prostate cancer patient advocacy community through a variety of activities such as teleconferences, webcasts, helplines, online patient support services, local community outreach, newsletters, radio programming, support groups, cancer resource directories, patient conferences, walks and runs, that are aimed at increasing awareness and empowerment among patients and caregivers.

"Like the AUA, Medivation is committed to advancing education and research, so we are honored to be acknowledged by such an outstanding organization for the work we are doing to advance the understanding around prostate cancer," said David Hung, M.D., founder, president & chief executive officer of Medivation. "We feel it is part of our mission and it is our privilege to give back to the community by supporting the informational needs of clinicians, patients and caregivers."

About Medivation, Inc. Medivation, Inc. is a biopharmaceutical company focused on the development and commercialization of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit www.medivation.com .

Contacts: Investors Anne Bowdidge (650) 218-6900 Media Samina Bari (415) 275-5893

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cargo Drones to Skyrocket with $9.14B Value by 2031

Updated Category News Views 141

Riding the Drone Wave I tell you what, folks, the whole business of cargo drones is getting frickin' interesting. These flying gizmos, once dismissed as science fiction, are now barging their way into logistics discussions like an uninvited guest who's too worthwhile to ignore. MarketsandMarkets™ reckons this market's about to smash through the $9 billion ceiling by...

Continue Reading
SiteOne Joins S&P SmallCap 600 Amid KKR's Integer Buyout

Updated Category News Views 99

Changes on the SmallCap Horizon Starting off, SiteOne Landscape Supply (NYSE: SITE) is hopping onto the S&P SmallCap 600 bandwagon. This shift activates just as the market revs up on November 19, 2026. SiteOne is stepping in as Integer Holdings Corp. (NYSE: ITGR) makes its grand exit, a move prompted by a significant acquisition by KKR & Co. Inc. (NYSE: KKR). KKR’s...

Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 113

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading
LA Hospitals Shine in Pulmonary Excellence Nationwide

Updated Category News Views 103

Los Angeles Community Hospitals' Recent Recognition You ever stroll into a hospital and wonder if you’re really getting the best care? Well, the folks over at Los Angeles Community Hospitals, covering LA, Norwalk, and Bellflower, just got a big nod from Healthgrades—yeah, the site everyone's checking to find decent healthcare options. They’ve landed among the top...

Continue Reading
Jones Soda Expands into Nutrition with UCAN Deal

Updated Category News Views 176

Well, Jones Soda Co. (CSE: JSDA) is stirring the pot with its recent move to acquire the UCAN functional nutrition assets. Popped the news on November 12, 2026, and it turns out they've shelled out a cool $700,000 in cash and taken on $500,000 in liabilities for the privilege. This isn't some casual shuffle of dollars and cents—this one's a strategic gambit aimed at...

Continue Reading
Hermes AI: A New Era in Market Analysis?

Updated Category News Views 88

Revolution or Just Another App? In a world where stock market insights are as cryptic as hieroglyphs to the average Joe, here comes the Hermes AI Analyzer, breaking onto the scene and promising to translate Wall Street's complex lingo into plain, simple language. It's the brainchild of Turkish engineer Umut Tugrul, who has spent decades in the trenches of software...

Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut

Updated Category News Views 91

A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...

Continue Reading
Nord Anglia Schools Shine with 13 Tes Awards Nominations

Updated Category News Views 154

Nord Anglia's Moment of Glory at Tes Awards You think you know the big players in the educational game? Well, guess again. Nord Anglia's come out swinging with a whopping 13 finalist nominations at the 2026 Tes Awards for International Schools. It ain't easy making waves in the education sector, but these folks are showing they've got what it takes to turn heads, not just...

Continue Reading
equipifi's BNPL Shop: New Ammo for Credit Unions

Updated Category News Views 87

equipifi's 'Shop': The Big Play in Banking Look, here’s the deal—equipifi just lobbed a new grenade into the finance battlefield, arming credit unions and community banks with 'Shop', their own Buy Now, Pay Later (BNPL) platform. The goal? To put them toe-to-toe with the big fintech wolves—something these smaller guys desperately needed. It's a meaty move, no...

Continue Reading
Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 114

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading

Top 5 Most Recently Viewed Articles

LXP Industrial Trust's Strong First Quarter Performance Revealed

Updated Category News Views 197

LXP Industrial Trust Reports Strong Financial Results Today, LXP Industrial Trust (NYSE: LXP), a real estate investment trust specializing in Class A warehouse and distribution facilities, outlines its robust performance for the first quarter of 2025. Key financial figures and strategic developments reflect the company's growth trajectory in the dynamic real estate...

Continue Reading
AI in Diagnostics: A Bright Future with Rapid Growth Ahead

Updated Category News Views 314

AI in Diagnostics Market Overview In recent years, the integration of Artificial Intelligence (AI) into the diagnostics sector has shown remarkable potential. As healthcare progresses, the reliance on AI technology for early disease detection and diagnosis is becoming increasingly vital. The current healthcare landscape is witnessing an upsurge in the occurrence of...

Continue Reading
Fund Manager Scott Bessent Bets Big on Trump's Economic Policies

Updated Category News Views 312

Scott Bessent's Strategic Bet on Trump As a prominent figure in the investment community, Scott Bessent's journey has seen significant highs and lows. Currently, he finds himself in a pivotal moment, leveraging the political climate surrounding President-elect Donald Trump to make strategic moves that might reshape his career and the future of Key Square Capital...

Continue Reading
Mifflinburg Bancorp and Northumberland Bancorp Unite for Growth

Updated Category News Views 161

Mifflinburg Bancorp and Northumberland Bancorp Unite Mifflinburg Bancorp, Inc. (OTCPK: MIFF) and Northumberland Bancorp (OTCPK: NUBC) have officially revealed a strategic merger that is poised to transform the financial landscape. This merger, described as a union of equals, will create a new entity with significant resources aimed at improving capabilities and...

Continue Reading
ZTE's CDO Unveils Future of Intelligence at Key Shanghai Event

Updated Category News Views 215

ZTE's Vision for Intelligent Evolution at MWC25 ZTE Corporation (0763.HK / 000063.SZ), a prominent provider of information and communication technology solutions, made a significant impact at MWC25 in Shanghai. During this year’s event, Cui Li, Chief Development Officer of ZTE, captivated an audience during her keynote address titled "Digital and Intelligent Evolution:...

Continue Reading